Journal of Infection 

TL;DR: This article reviews the occurrence mechanism and treatment strategies of the COVID-19 virus-induced inflammatory storm in attempt to provide valuable medication guidance for clinical treatment.

TL;DR: Clinical manifestations such as fever, shortness of breath or dyspnea were associated with the progression of disease, and laboratory examination such as aspartate amino transferase(AST) > 40U/L, creatinine(Cr) ≥ 133mol/l, hypersensitive cardiac troponin I(hs-cTnI) > 28pg/mL, procalcitonin(PCT) > 0.5mg/L predicted the deterioration of disease.

TL;DR: A retrospective study of patients with new coronavirus pneumonia who were hospitalized in Hainan Provincial People's Hospital from January 15, 2020 to February 18, 2020, finds that elderly patients with COVID-19 are more likely to progress to severe disease.

TL;DR: A low proportion of COVID-19 patients have a bacterial co-infection; less than in previous influenza pandemics; and these findings do not support the routine use of antibiotics in the management of confirmed CO VID-19 infection.

TL;DR: The measures to prevent transmission was very successful at early stage, the next steps on the COVID-19 infection should be focused on early isolation of patients and quarantine for close contacts in families and communities in Beijing.